Tetraplegia is a massively limiting condition, often caused by serious accidents, in which individuals are unable to move their legs...
Speak your mind! – Pilot clinical study with severely paralyzed patients
CorTec is part of an international clinical study that will enable severely paralyzed people to communicate again – with the...
CorTec’ Brain Interchange implant system on track for first-in-man study, funded by the NIH
The proprietary CorTec neuromodulation system “Brain Interchange” was developed for the discovery of novel neurotherapies. With funding by the...
INTENSE: Dutch neurotechnology network on brain-machine interfaces
With the support of the Netherlands Organisation for Scientific Research, a new research network was established in 2021 that aims...
Bernstein-CorTec Award & the Bernstein Special Seminar
For the second time the Bernstein-CorTec Award was given in recognition of outstanding achievements at the University of Freiburg. The...
Seeing the light for treatment-resistant epilepsy
Most users of CorTec’s implantable electrodes use electrical energy to power their neurostimulation device. Our long-standing collaboration partner Synergia Medical ...
New Member of the Management Team at CorTec
As CorTec grows and pursues novel therapeutic applications together with partners, the attendant regulatory, quality assurance, and clinical complexities facing...
Call for Nominations – the Bernstein-CorTec Award 2021
For the second time we will be able to present the Bernstein-CorTec Award this year. The cooperation between CorTec and...
